wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40397988-B83DF537-FECC-4C20-899B-F613DB433AA2
Q40397988-B83DF537-FECC-4C20-899B-F613DB433AA2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40397988-B83DF537-FECC-4C20-899B-F613DB433AA2
A randomized phase 2 study of MK-2206 versus everolimus in refractory renal cell carcinoma.
P2860
Q40397988-B83DF537-FECC-4C20-899B-F613DB433AA2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40397988-B83DF537-FECC-4C20-899B-F613DB433AA2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ebca43fc2011bdcdc6b2ddc7e158129892c5ab40
P2860
A phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor-targeted therapies.